Tag: oncology trials
Triple-Drug Therapy Extends Survival in Advanced Prostate Cancer Trial
Triple-drug combination therapy significantly improved survival outcomes in advanced prostate cancer trial. The approach combines PARP inhibition with androgen-signaling blockers…
Zanidatamab Plus Chemotherapy Shows 56% Improvement in HER2+ Gastric Cancer
Zanidatamab plus chemotherapy reduced disease progression risk by 44% compared to trastuzumab in HER2-positive gastroesophageal cancer patients. The phase III…
Submit Your Paper to GMJ
No APC until January 2027.